pharmaceuticals-and-healthcare

United States Oral Anticoagulant Market Report 2017


Published On : Mar 2017

Category : Pharmaceutical

No. of Pages : 96 pages

  • $3800
  • $7600

Please click below to avail discount on this report

In this report, the United States Oral Anticoagulant market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into six regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Oral Anticoagulant in these regions, from 2012 to 2022 (forecast).

United States Oral Anticoagulant market competition by top manufacturers/players, with Oral Anticoagulant sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Akers Biosciences
Pfizer
Eisai
AstraZeneca
Eli Lilly
Medicure
GlaxoSmithKline
Novartis AG
Sanofi

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
Warfarin
Dabigatran
Rivaroxaban
Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Oral Anticoagulant for each application, including
Thromboembolic Disease
Disseminated Intravascular Coagulation
Cardiovascular Surgery
Others

In the recent times, the global market for United states oral anticoagulant market report 2017 has surfaced as one of the most promising markets in the pharmaceutical industry, thanks to the significant rise in research and development activities by leading vendors of United states oral anticoagulant market report 2017 across the world. Manufacturers have turned to technological innovations and data-driven customization to satisfy the augmenting consumer demand for efficiency and more accuracy in results, leading to an increased usage of technology in the United states oral anticoagulant market report 2017 production processes, which is also reflecting positively on the growth of this market.

The research report on the United states oral anticoagulant market report 2017 is an analytical study which comprehensively analyzes the competitive framework of this market. Using a number of effective assessment tools, such as porter’s five forces and value chain analysis, it performs in-depth analyses of the production and supply as well as the demand and sales of United states oral anticoagulant market report 2017 and provides deep insights into the future prospects of this market.

The study begins with a detailed overview of the market for United states oral anticoagulant market report 2017, including the definition, classification, and industry chain structure of United states oral anticoagulant market report 2017, and move forward to cover every aspect of this market, counting several criteria based on which the market is classified. Focusing specifically on the key trends, it further evaluates the overall performance of this market during the assessment period. With chemical industry undergoing a phase of technological disruption, innovations in products are likely to shape the future of the United states oral anticoagulant market report 2017.

In this research report, apart from the trends, the driving forces, restraints, and opportunities have also been taken into consideration to determine the market’s future. Further, it offers an estimation of the market size in terms of value (US$) and in volume (kilo tons) and talks about the key segments and the geographical subdivisions of the market for United states oral anticoagulant market report 2017 in details. It provides in-depth information on the development trends and the policies and regulations, concerning United states oral anticoagulant market report 2017, implemented in each of the geographical segments. The predominant applications of the United states oral anticoagulant market report 2017 have also been discussed at length in this research study.

With all these analyses and information, this report can act as a valuable guide to readers looking to gain a clear understanding of all the factors that are influencing the market for United states oral anticoagulant market report 2017 at present and are projected to remain doing so over the forecast period. Readers will also benefit significantly from the important information regarding this market, provided in the forms of figures and tables in the research report.

Additionally, the information on the latest developments in this market, both, at the global as well as regional level, is expected to enhance the decision-making capability of the reader. Up-to-date information on various specifications, buyer analysis, their purchasing volume, prices, and price analysis, and deep insights on the leading suppliers have also been provided in this study for the readers.

At last, the report offers key industry recommendations to companies looking to venture into the United states oral anticoagulant market report 2017 from both the perspectives, i.e. demand and supply. The main objective of this research study is to assist stakeholders operating in this market in creating efficient counter strategies to gain an edge over their competitors.

Table of Contents

United States Oral Anticoagulant Market Report 2017
1 Oral Anticoagulant Overview
1.1 Product Overview and Scope of Oral Anticoagulant
1.2 Classification of Oral Anticoagulant by Product Category
1.2.1 United States Oral Anticoagulant Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Oral Anticoagulant Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Warfarin
1.2.4 Dabigatran
1.2.5 Rivaroxaban
1.2.6 Others
1.3 United States Oral Anticoagulant Market by Application/End Users
1.3.1 United States Oral Anticoagulant Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Thromboembolic Disease
1.3.3 Disseminated Intravascular Coagulation
1.3.4 Cardiovascular Surgery
1.3.5 Others
1.4 United States Oral Anticoagulant Market by Region
1.4.1 United States Oral Anticoagulant Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Oral Anticoagulant Status and Prospect (2012-2022)
1.4.3 Southwest Oral Anticoagulant Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Oral Anticoagulant Status and Prospect (2012-2022)
1.4.5 New England Oral Anticoagulant Status and Prospect (2012-2022)
1.4.6 The South Oral Anticoagulant Status and Prospect (2012-2022)
1.4.7 The Midwest Oral Anticoagulant Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Oral Anticoagulant (2012-2022)
1.5.1 United States Oral Anticoagulant Sales and Growth Rate (2012-2022)
1.5.2 United States Oral Anticoagulant Revenue and Growth Rate (2012-2022)

2 United States Oral Anticoagulant Market Competition by Players/Suppliers
2.1 United States Oral Anticoagulant Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Oral Anticoagulant Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Oral Anticoagulant Average Price by Players/Suppliers (2012-2017)
2.4 United States Oral Anticoagulant Market Competitive Situation and Trends
2.4.1 United States Oral Anticoagulant Market Concentration Rate
2.4.2 United States Oral Anticoagulant Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Oral Anticoagulant Manufacturing Base Distribution, Sales Area, Product Type

3 United States Oral Anticoagulant Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Oral Anticoagulant Sales and Market Share by Region (2012-2017)
3.2 United States Oral Anticoagulant Revenue and Market Share by Region (2012-2017)
3.3 United States Oral Anticoagulant Price by Region (2012-2017)

4 United States Oral Anticoagulant Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Oral Anticoagulant Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Oral Anticoagulant Revenue and Market Share by Type (2012-2017)
4.3 United States Oral Anticoagulant Price by Type (2012-2017)
4.4 United States Oral Anticoagulant Sales Growth Rate by Type (2012-2017)

5 United States Oral Anticoagulant Sales (Volume) by Application (2012-2017)
5.1 United States Oral Anticoagulant Sales and Market Share by Application (2012-2017)
5.2 United States Oral Anticoagulant Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Oral Anticoagulant Players/Suppliers Profiles and Sales Data
6.1 Akers Biosciences
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Oral Anticoagulant Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Akers Biosciences Oral Anticoagulant Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Pfizer
6.2.2 Oral Anticoagulant Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Pfizer Oral Anticoagulant Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Eisai
6.3.2 Oral Anticoagulant Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Eisai Oral Anticoagulant Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 AstraZeneca
6.4.2 Oral Anticoagulant Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 AstraZeneca Oral Anticoagulant Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Eli Lilly
6.5.2 Oral Anticoagulant Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Eli Lilly Oral Anticoagulant Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Medicure
6.6.2 Oral Anticoagulant Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Medicure Oral Anticoagulant Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 GlaxoSmithKline
6.7.2 Oral Anticoagulant Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 GlaxoSmithKline Oral Anticoagulant Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Novartis AG
6.8.2 Oral Anticoagulant Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Novartis AG Oral Anticoagulant Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Sanofi
6.9.2 Oral Anticoagulant Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Sanofi Oral Anticoagulant Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview

7 Oral Anticoagulant Manufacturing Cost Analysis
7.1 Oral Anticoagulant Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Oral Anticoagulant

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Oral Anticoagulant Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Oral Anticoagulant Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Oral Anticoagulant Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Oral Anticoagulant Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Oral Anticoagulant Sales Volume Forecast by Type (2017-2022)
11.3 United States Oral Anticoagulant Sales Volume Forecast by Application (2017-2022)
11.4 United States Oral Anticoagulant Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer


List of Tables and Figures

Figure Product Picture of Oral Anticoagulant
Figure United States Oral Anticoagulant Market Size (Sales Volume) Comparison by Type (2012-2022)
Figure United States Oral Anticoagulant Sales Volume Market Share by Type (Product Category) in 2016
Figure Warfarin Product Picture
Figure Dabigatran Product Picture
Figure Rivaroxaban Product Picture
Figure Others Product Picture
Figure United States Oral Anticoagulant Market Size (Consumption) Comparison by Application (2012-2022)
Figure United States Sales Market Share of Oral Anticoagulant by Application in 2016
Figure Thromboembolic Disease Examples
Figure Disseminated Intravascular Coagulation Examples
Figure Cardiovascular Surgery Examples
Figure Others Examples
Figure United States Oral Anticoagulant Market Size (Value) Comparison by Region (2012-2022)
Figure The West Oral Anticoagulant Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Oral Anticoagulant Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Oral Anticoagulant Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Oral Anticoagulant Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Oral Anticoagulant Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Oral Anticoagulant Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Oral Anticoagulant Sales and Growth Rate (2012-2022)
Figure United States Oral Anticoagulant Revenue and Growth Rate (2012-2022)
Figure United States Oral Anticoagulant Market Major Players Product Sales Volume (2012-2017)
Table United States Oral Anticoagulant Sales of Key Players/Suppliers (2012-2017)
Table United States Oral Anticoagulant Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Oral Anticoagulant Sales Share by Players/Suppliers
Figure 2017 United States Oral Anticoagulant Sales Share by Players/Suppliers
Figure United States Oral Anticoagulant Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Oral Anticoagulant Revenue by Players/Suppliers (2012-2017)
Table United States Oral Anticoagulant Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Oral Anticoagulant Revenue Share by Players/Suppliers
Figure 2017 United States Oral Anticoagulant Revenue Share by Players/Suppliers
Table United States Market Oral Anticoagulant Average Price of Key Players/Suppliers (2012-2017)
Figure United States Market Oral Anticoagulant Average Price of Key Players/Suppliers in 2016
Figure United States Oral Anticoagulant Market Share of Top 3 Players/Suppliers
Figure United States Oral Anticoagulant Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Oral Anticoagulant Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Oral Anticoagulant Product Category
Table United States Oral Anticoagulant Sales by Region (2012-2017)
Table United States Oral Anticoagulant Sales Share by Region (2012-2017)
Figure United States Oral Anticoagulant Sales Share by Region (2012-2017)
Figure United States Oral Anticoagulant Sales Market Share by Region in 2016
Table United States Oral Anticoagulant Revenue and Market Share by Region (2012-2017)
Table United States Oral Anticoagulant Revenue Share by Region (2012-2017)
Figure United States Oral Anticoagulant Revenue Market Share by Region (2012-2017)
Figure United States Oral Anticoagulant Revenue Market Share by Region in 2016
Table United States Oral Anticoagulant Price by Region (2012-2017)
Table United States Oral Anticoagulant Sales by Type (2012-2017)
Table United States Oral Anticoagulant Sales Share by Type (2012-2017)
Figure United States Oral Anticoagulant Sales Share by Type (2012-2017)
Figure United States Oral Anticoagulant Sales Market Share by Type in 2016
Table United States Oral Anticoagulant Revenue and Market Share by Type (2012-2017)
Table United States Oral Anticoagulant Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Oral Anticoagulant by Type (2012-2017)
Figure Revenue Market Share of Oral Anticoagulant by Type in 2016
Table United States Oral Anticoagulant Price by Types (2012-2017)
Figure United States Oral Anticoagulant Sales Growth Rate by Type (2012-2017)
Table United States Oral Anticoagulant Sales by Application (2012-2017)
Table United States Oral Anticoagulant Sales Market Share by Application (2012-2017)
Figure United States Oral Anticoagulant Sales Market Share by Application (2012-2017)
Figure United States Oral Anticoagulant Sales Market Share by Application in 2016
Table United States Oral Anticoagulant Sales Growth Rate by Application (2012-2017)
Figure United States Oral Anticoagulant Sales Growth Rate by Application (2012-2017)
Table Akers Biosciences Basic Information List
Table Akers Biosciences Oral Anticoagulant Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Akers Biosciences Oral Anticoagulant Sales Growth Rate (2012-2017)
Figure Akers Biosciences Oral Anticoagulant Sales Market Share in United States (2012-2017)
Figure Akers Biosciences Oral Anticoagulant Revenue Market Share in United States (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Oral Anticoagulant Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer Oral Anticoagulant Sales Growth Rate (2012-2017)
Figure Pfizer Oral Anticoagulant Sales Market Share in United States (2012-2017)
Figure Pfizer Oral Anticoagulant Revenue Market Share in United States (2012-2017)
Table Eisai Basic Information List
Table Eisai Oral Anticoagulant Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Eisai Oral Anticoagulant Sales Growth Rate (2012-2017)
Figure Eisai Oral Anticoagulant Sales Market Share in United States (2012-2017)
Figure Eisai Oral Anticoagulant Revenue Market Share in United States (2012-2017)
Table AstraZeneca Basic Information List
Table AstraZeneca Oral Anticoagulant Sales, Revenue, Price and Gross Margin (2012-2017)
Figure AstraZeneca Oral Anticoagulant Sales Growth Rate (2012-2017)
Figure AstraZeneca Oral Anticoagulant Sales Market Share in United States (2012-2017)
Figure AstraZeneca Oral Anticoagulant Revenue Market Share in United States (2012-2017)
Table Eli Lilly Basic Information List
Table Eli Lilly Oral Anticoagulant Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Eli Lilly Oral Anticoagulant Sales Growth Rate (2012-2017)
Figure Eli Lilly Oral Anticoagulant Sales Market Share in United States (2012-2017)
Figure Eli Lilly Oral Anticoagulant Revenue Market Share in United States (2012-2017)
Table Medicure Basic Information List
Table Medicure Oral Anticoagulant Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Medicure Oral Anticoagulant Sales Growth Rate (2012-2017)
Figure Medicure Oral Anticoagulant Sales Market Share in United States (2012-2017)
Figure Medicure Oral Anticoagulant Revenue Market Share in United States (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Oral Anticoagulant Sales, Revenue, Price and Gross Margin (2012-2017)
Figure GlaxoSmithKline Oral Anticoagulant Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline Oral Anticoagulant Sales Market Share in United States (2012-2017)
Figure GlaxoSmithKline Oral Anticoagulant Revenue Market Share in United States (2012-2017)
Table Novartis AG Basic Information List
Table Novartis AG Oral Anticoagulant Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Novartis AG Oral Anticoagulant Sales Growth Rate (2012-2017)
Figure Novartis AG Oral Anticoagulant Sales Market Share in United States (2012-2017)
Figure Novartis AG Oral Anticoagulant Revenue Market Share in United States (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Oral Anticoagulant Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Sanofi Oral Anticoagulant Sales Growth Rate (2012-2017)
Figure Sanofi Oral Anticoagulant Sales Market Share in United States (2012-2017)
Figure Sanofi Oral Anticoagulant Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Oral Anticoagulant
Figure Manufacturing Process Analysis of Oral Anticoagulant
Figure Oral Anticoagulant Industrial Chain Analysis
Table Raw Materials Sources of Oral Anticoagulant Major Players/Suppliers in 2016
Table Major Buyers of Oral Anticoagulant
Table Distributors/Traders List
Figure United States Oral Anticoagulant Sales Volume and Growth Rate Forecast (2017-2022)
Figure United States Oral Anticoagulant Revenue and Growth Rate Forecast (2017-2022)
Figure United States Oral Anticoagulant Price Trend Forecast (2017-2022)
Table United States Oral Anticoagulant Sales Volume Forecast by Type (2017-2022)
Figure United States Oral Anticoagulant Sales Volume Forecast by Type (2017-2022)
Figure United States Oral Anticoagulant Sales Volume Forecast by Type in 2022
Table United States Oral Anticoagulant Sales Volume Forecast by Application (2017-2022)
Figure United States Oral Anticoagulant Sales Volume Forecast by Application (2017-2022)
Figure United States Oral Anticoagulant Sales Volume Forecast by Application in 2022
Table United States Oral Anticoagulant Sales Volume Forecast by Region (2017-2022)
Table United States Oral Anticoagulant Sales Volume Share Forecast by Region (2017-2022)
Figure United States Oral Anticoagulant Sales Volume Share Forecast by Region (2017-2022)
Figure United States Oral Anticoagulant Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Request a Sample Copy

  • * :
  • * :
  • * :
  • * :
  • * :
  • :
  • * :
  • * indicates required field.

LATEST NEWS


Back To Top